TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 51.20
+0.90 (1.79%)
Jun 18, 2026, 12:48 PM CST
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 1.97 billion as of June 18, 2026. Its market cap has increased by 0.79% in one year.
Market Cap
1.97B
Enterprise Value
1.19B
Revenue
1.34B
Ranking
n/a
PE Ratio
13.33
Stock Price
51.20
Market Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has increased from 1.96B to 1.97B, an increase of 0.19%. That is a compound annual growth rate of 0.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.97B | -12.48% |
| Dec 31, 2025 | 2.25B | -4.57% |
| Dec 31, 2024 | 2.35B | 21.87% |
| Dec 29, 2023 | 1.93B | 5.78% |
| Dec 30, 2022 | 1.83B | 6.85% |
| Dec 30, 2021 | 1.71B | -24.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yoda Pharmaceuticals | 3.27B |
| Tien Liang BioTech | 3.26B |
| Maywufa Company | 2.90B |
| Merdury Biopharmaceutical | 2.74B |
| Allied Biotech | 2.73B |
| Johnson Chemical Pharmaceutical Works | 2.44B |
| PhytoHealth | 2.38B |
| GeneFerm Biotechnology | 1.40B |